发明名称 Biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-{[(r)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroxyquinoline -5-yl)ethylamino]methyl}phenylcarbamoyl)-butyl]methylcarbamoyl}ethyl)-pipridine-4-yl ester, pharmaceutical compositions comprising it, uses thereof in therapy and some intermediates in the process of preparing the compound
摘要 A compound of formula I: or a pharmaceutically acceptable salt thereof having muscarinic receptor antagonist and ²2 adrenergic receptor agonist activity.
申请公布号 IL215554(A) 申请公布日期 2014.08.31
申请号 IL20110215554 申请日期 2011.10.05
申请人 THERAVANCE INC. 发明人
分类号 A61K;A61P;C07D 主分类号 A61K
代理机构 代理人
主权项
地址
您可能感兴趣的专利